WEST LAFAYETTE — On Target Laboratories LLC and Purdue University are clinically investigating optical imaging technology that could “light up” cancer cells and help surgeons remove more cancerous tissue than previously possible during surgical procedures.

The technology was developed by Philip Low, the Ralph C. Corley Distinguished Professor of Chemistry at Purdue University, director of the Purdue University Center for Drug Discovery and co-founder of On Target Laboratories.

“The optical imaging technology is another important milestone in cancer treatment advancements being piloted by Phil Low and other promising researchers at Purdue,” said Mitch Daniels, Purdue University president. “It also is a prime example of how innovations being developed in Indiana can be advanced through partnerships with other world-class institutions like the Leiden University Medical Center in the Netherlands.”